Grab our FREE TRIAL for daily intraday updates click here http://www.ripplesadvisory.com/free-trial.php
Sun Pharmaceutical Industries has dipped 2% to Rs 615 on the BSE, its lowest level since November 9, 2016. In past 14 trading days, the stock of pharma company was down 15% erasing its entire gain recorded post July-September (Q2FY17) results. The S&P BSE Sensex was down 0.76% during the same period.
Between November 9 and December 1, post Q2F17 results, the stock had outperformed the market by gaining 9% from Rs 661 to Rs 722, as compared to 2.5% decline in the benchmark index.
Sun Pharmaceutical Industries has dipped 2% to Rs 615 on the BSE, its lowest level since November 9, 2016. In past 14 trading days, the stock of pharma company was down 15% erasing its entire gain recorded post July-September (Q2FY17) results. The S&P BSE Sensex was down 0.76% during the same period.
No comments:
Post a Comment